These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 27824281

  • 1. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ, Lai HW, Zhang Y, Feng B, Xiao X, Zhang HM, Li ZQ, Qi XR.
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [Abstract] [Full Text] [Related]

  • 2. Significant solubility of carbon dioxide in Soluplus® facilitates impregnation of ibuprofen using supercritical fluid technology.
    Obaidat R, Alnaief M, Jaeger P.
    Pharm Dev Technol; 2018 Sep; 23(7):697-705. PubMed ID: 28375669
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Study on the properties of felodipine solid dispersions prepared by different technologies].
    Shi NQ, Zhang H, Zhang Y, Feng B, Li ZQ, Qi XR.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec 18; 48(6):1067-1073. PubMed ID: 27987515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
    Hughey JR, Keen JM, Miller DA, Kolter K, Langley N, McGinity JW.
    Eur J Pharm Sci; 2013 Mar 12; 48(4-5):758-66. PubMed ID: 23348153
    [Abstract] [Full Text] [Related]

  • 10. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM, Lu W, Park JB, Morott JT, Alsulays BB, Majumdar S, Langley N, Kolter K, Gryczke A, Repka MA.
    AAPS PharmSciTech; 2015 Aug 12; 16(4):824-34. PubMed ID: 25567525
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M, Wu C, Fu Q, Di D, Kuang X, Wang C, He Z, Wang J, Sun J.
    Int J Pharm; 2016 Apr 30; 503(1-2):238-46. PubMed ID: 26869398
    [Abstract] [Full Text] [Related]

  • 13. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
    Semjonov K, Salm M, Lipiäinen T, Kogermann K, Lust A, Laidmäe I, Antikainen O, Strachan CJ, Ehlers H, Yliruusi J, Heinämäki J.
    Int J Pharm; 2018 Apr 25; 541(1-2):188-197. PubMed ID: 29481945
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
    Davis MT, Potter CB, Mohammadpour M, Albadarin AB, Walker GM.
    Int J Pharm; 2017 Mar 15; 519(1-2):365-372. PubMed ID: 28131850
    [Abstract] [Full Text] [Related]

  • 17. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y, Jones DS, Andrews GP.
    Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.